Open Access Research Protocol

An Audit of the Predictive value of SNOT 22 Test in Evaluating Nasal Surgeries Emersons Green /Devizes NHS Treatment Centers-UK

Samir Gendy*

Department of ENT Surgery, Ireland

Corresponding Author

Received Date: May 16, 2019;  Published Date: May 24, 2019


The Sino-nasal outcome test (SNOT22) has been widely adopted in clinical practice and has been declared as the most suitable sinonasal outcome scoring system. It is simple disease specific encompassing 22 symptoms reflecting health burden of the rhino- logical patients. Each item quantifies symptoms severity from 0 (no problem) to 5 (worst symptom). The sum of each item results in a maximum score of 110. High score indicates poor outcome. The SNOT22 is a validated questionnaire of disease specific, quality of life-related measures of sinonasal function that has demonstrated good reliability, validity, and responsiveness and is been used in various Rhinological procedures for example septoplasty, Functional endoscopic sinus surgery, Endoscopic turbinoplasty. SNOT22 is recommended by the European Position Paper on Rhinosinusitis and Nasal polyps EPOS 2012 as the most adequate tool to evaluate the effectiveness of surgery for chronic rhino sinusitis [1]. This Audit reflects a single Surgeon experience of using SNOT22 in evaluating a cohort of patients with Rhinological disease comparing the preoperative and postoperative scoring to reflect the outcome of various Rhinological procedures.

Signup for Newsletter
Scroll to Top